The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The prognostic role of circulating tumor DNA (ctDNA) clearance as a biomarker in localized and metastatic renal cell carcinoma (RCC): A single-center experience.
 
Adanma Ayanambakkam
Consulting or Advisory Role - AVEO; Pfizer/Astellas
 
Bibi Maryam
No Relationships to Disclose
 
Priyanka Vallabhaneni
No Relationships to Disclose
 
Haripriya Andanamala
No Relationships to Disclose
 
Vishnu Nagalapuram
No Relationships to Disclose
 
Joshua Glover
No Relationships to Disclose
 
Tyler Gunter
Employment - University of Oklahoma Health Sciences Center
Research Funding - Mevion Medical Systems (Inst)
 
Kelly Stratton
Honoraria - Bayer; Dendreon (Inst); Janssen; Johnson & Johnson/Janssen; Merck; MJH Life Sciences; Oakstone Publishing; Oakstone Publishing (Inst); Sun Pharma; Urology times
Consulting or Advisory Role - AMRO Pharma (Inst); Bayer (Inst); Bayer (Inst); Clovis Oncology (Inst); Dendreon (Inst); Ebix (Inst); Elsevier (Inst); Janssen (Inst); Large Urology Group Practice Association (Inst); Merck (Inst); Myriad Genetics (Inst); Sanofi (Inst)
Speakers' Bureau - Arkansas Urology; Bayer; Bayer Speaker Bureau
Research Funding - Advantage Pharmaceuticals (Inst); Alliance Foundation Trials (Inst); Anchiano (Inst); Astellas ENACT CTA (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Dendreon (Inst); EMD Serono (Inst); EMD Serono (Inst); Ferring (Inst); Genentech (Inst); Myovant Sciences (Inst); Myriad Genetics (Inst); Myriad Genetics (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Roche/Genentech (Inst); RTOG (Inst); TARIS Biomedical (Inst); TARIS Biomedical (Inst)
Travel, Accommodations, Expenses - Dendreon; Dendreon (Inst); Myriad Genetics
 
Michael Cookson
Honoraria - AstraZeneca/MedImmune; Bayer; Clovis Oncology; FerGene; Lantheus Medical Imaging; MJH Life Sciences; Myovant Sciences; Pacific Edge Biotechnology; Remedica Medical Education & Publishing
Consulting or Advisory Role - Bayer; Janssen Biotech; LynxDx; Myovant Sciences; Nonagen Bioscience; Pfizer; Pfizer; Prokarium; Propella Therapeutics; Signatera
Research Funding - Ferring (Inst); MDxHealth (Inst)
Travel, Accommodations, Expenses - Janssen; Pfizer; Progenics; Progenics
 
Brian Cross
No Relationships to Disclose
 
Sanjay Patel
No Relationships to Disclose
 
Andrew McIntosh
No Relationships to Disclose
 
Hassan Abushukair
No Relationships to Disclose
 
Minh Phan
No Relationships to Disclose
 
Ryan Nipp
No Relationships to Disclose
 
Arnab Basu
Honoraria - Cardinal Health; Eisai; Gilead Sciences; Natera
Consulting or Advisory Role - Bristol-Myers Squibb/Pfizer; EMD Serono; Seagen
Speakers' Bureau - Eisai
Research Funding - Astellas Pharma (Inst); AVEO (Inst); Bristol-Myers Squibb/Celgene (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Merck (Inst); Natera (Inst)
 
Rana McKay
Consulting or Advisory Role - Ambrx; Ambrx; Arcus Biosciences; Astellas Medivation; AstraZeneca; AVEO; Bayer; Blue Earth Diagnostics; Bristol-Myers Squibb; Calithera Biosciences; Caris Life Sciences; Dendreon; Esiai; Exelixis; Janssen; Lilly; Merck; Myovant Sciences; NeoMorph; Novartis; Pfizer; Sanofi; Seagen; Sorrento Therapeutics; Sumitomo Pharma Oncology; Telix Pharmaceuticals; Tempus; Vividion Therapeutics
Research Funding - Artera (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol Myers Squibb (Inst); Exelixis (Inst); Oncternal Therapeutics (Inst); Tempus (Inst)